Literature DB >> 22236370

The transcriptome of the adenovirus infected cell.

Hongxing Zhao1, Martin Dahlö, Anders Isaksson, Ann-Christine Syvänen, Ulf Pettersson.   

Abstract

Alternations of cellular gene expression following an adenovirus type 2 infection of human primary cells were studied by using superior sensitive cDNA sequencing. In total, 3791 cellular genes were identified as differentially expressed more than 2-fold. Genes involved in DNA replication, RNA transcription and cell cycle regulation were very abundant among the up-regulated genes. On the other hand, genes involved in various signaling pathways including TGF-β, Rho, G-protein, Map kinase, STAT and NF-κB stood out among the down-regulated genes. Binding sites for E2F, ATF/CREB and AP2 were prevalent in the up-regulated genes, whereas binding sites for SRF and NF-κB were dominant among the down-regulated genes. It is evident that the adenovirus has gained a control of the host cell cycle, growth, immune response and apoptosis at 24 h after infection. However, efforts from host cell to block the cell cycle progression and activate an antiviral response were also observed. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22236370     DOI: 10.1016/j.virol.2011.12.006

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  22 in total

1.  Pervasive initiation and 3'-end formation of poxvirus postreplicative RNAs.

Authors:  Zhilong Yang; Craig A Martens; Daniel P Bruno; Stephen F Porcella; Bernard Moss
Journal:  J Biol Chem       Date:  2012-07-24       Impact factor: 5.157

2.  Arenavirus infection induces discrete cytosolic structures for RNA replication.

Authors:  Nicholas L Baird; Joanne York; Jack H Nunberg
Journal:  J Virol       Date:  2012-08-08       Impact factor: 5.103

3.  Normal human cell proteins that interact with the adenovirus type 5 E1B 55kDa protein.

Authors:  George Hung; S J Flint
Journal:  Virology       Date:  2017-01-27       Impact factor: 3.616

4.  Comparison of the Life Cycles of Genetically Distant Species C and Species D Human Adenoviruses Ad6 and Ad26 in Human Cells.

Authors:  Mallory A Turner; Sumit Middha; Sean E Hofherr; Michael A Barry
Journal:  J Virol       Date:  2015-09-30       Impact factor: 5.103

5.  Adenovirus small E1A employs the lysine acetylases p300/CBP and tumor suppressor Rb to repress select host genes and promote productive virus infection.

Authors:  Roberto Ferrari; Dawei Gou; Gauri Jawdekar; Sarah A Johnson; Miguel Nava; Trent Su; Ahmed F Yousef; Nathan R Zemke; Matteo Pellegrini; Siavash K Kurdistani; Arnold J Berk
Journal:  Cell Host Microbe       Date:  2014-11-12       Impact factor: 21.023

6.  Unabated adenovirus replication following activation of the cGAS/STING-dependent antiviral response in human cells.

Authors:  Eric Lam; Erik Falck-Pedersen
Journal:  J Virol       Date:  2014-10-08       Impact factor: 5.103

7.  De novo derivation of proteomes from transcriptomes for transcript and protein identification.

Authors:  Vanessa C Evans; Gary Barker; Kate J Heesom; Jun Fan; Conrad Bessant; David A Matthews
Journal:  Nat Methods       Date:  2012-11-11       Impact factor: 28.547

8.  Transcriptome analysis of porcine thymus following porcine cytomegalovirus infection.

Authors:  Xiao Liu; Zhiwen Xu; Ling Zhu; Shan Liao; Wanzhu Guo
Journal:  PLoS One       Date:  2014-11-25       Impact factor: 3.240

9.  Transcriptome sequencing and development of an expression microarray platform for liver infection in adenovirus type 5-infected Syrian golden hamsters.

Authors:  Baoling Ying; Karoly Toth; Jacqueline F Spencer; Rajeev Aurora; William S M Wold
Journal:  Virology       Date:  2015-08-28       Impact factor: 3.616

10.  MicroRNA transcriptome analysis of porcine vital organ responses to immunosuppressive porcine cytomegalovirus infection.

Authors:  Xiao Liu; Haoche Wei; Shan Liao; Jianheng Ye; Ling Zhu; Zhiwen Xu
Journal:  Virol J       Date:  2018-01-18       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.